Australia markets open in 41 minutes

ABBV Dec 2021 115.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.5300+0.0300 (+0.86%)
As of 3:30PM EST. Market open.
Full screen
Previous close3.5000
Open3.5000
Bid3.3000
Ask3.5000
Strike115.00
Expiry date2021-12-17
Day's range3.4500 - 4.1100
Contract rangeN/A
Volume45
Open interest13.73k
  • Zacks

    REGENXBIO (RGNX) DMD Gene Therapy Gets Orphan Drug Status

    REGENXBIO (RGNX) is developing a gene therapy candidate, RGX-202, for treating DMD, which is currently in the pre-clinical stage. An IND application is expected by the end of 2021.

  • PR Newswire

    AbbVie to Present at the Evercore ISI Conference

    AbbVie (NYSE: ABBV) will participate in the 4th Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 2, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 11:10 a.m. CT.

  • PR Newswire

    AbbVie to Present at the Piper Sandler Healthcare Conference

    AbbVie (NYSE: ABBV) will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on Wednesday, December 1, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 9:30 a.m. CT.